Medical Device News Magazine

ForSight Robotics Expands Leadership Team with Appointment of Sharon Levita As CFO

Seasoned medical device executive Sharon Levita to join the company

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

ForSight Robotics, a pioneer of robotic eye surgery, announced today the appointment of Sharon Levita as Chief Financial Officer (CFO), effective September 1, 2023. Levita will lead ForSight Robotics’ strategic and financial operations, focusing on driving business strategies, expanding strategic partnerships, and managing financial and growth objectives.

Levita brings over 20 years of industry experience working with private and publicly-listed (NASDAQ and TASE) companies. Most recently, Levita served as Medtronic’s Business Development and Strategy Leader at the company’s Cranial and Spinal Technologies operating unit, and as VP of Business Operations and Medtronic Site Lead (formerly robotic spine surgery company Mazor Robotics) in Israel. Prior to this, Levita served as CFO and VP of Business Operations at Mazor Robotics for over a decade and led the company’s $1.6 billion acquisition by Medtronic in 2018. Her previous experience includes various leadership roles at medical laser company Lumenis and at KPMG Hungary.

“Sharon is a proven leader, dedicated to driving forward healthcare innovation,” said Dr. Joseph Nathan, ForSight Robotics co-founder, president, and chief medical officer. “Her expertise and vast management experience in global medical technology companies, from developing successful go-to-market strategies to expanding global partnerships, are unparalleled and aligned with the company’s vision. We are thrilled to welcome Sharon to our team as we continue advancing in the development of our ORYOM Surgical Robotics Platform.”

“This is such an exciting time to join ForSight Robotics,” said Sharon Levita. “The company has significant potential to help millions of patients around the world. I value its mission to democratize quality surgical eye care and am eager to work together with the world-class team to strengthen the company’s forward momentum and together, have a global impact.”

In the past year, ForSight Robotics raised a record $55 million Series A funding round, doubled in size to 50 employees, and expanded its leadership team with the appointments of Dr. Yaron Levinson as Head of Product and Ran Mendelewicz as Head of Robotics. Levinson joined the company following over a decade in the surgical robotics industry, most recently as VP R&D at surgical robotics company Momentis Surgical, where he supported regulatory processes to receive FDA approval for the company’s robotic system. Mendelewicz joined ForSight Robotics following 20 years in the medical device industry, most recently as VP R&D at intraocular implant company Nano Retina.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”